Aurora Cannabis Inc. - Common Shares (ACB) analyst actions
Rating and price-target actions on ACB in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ACB overview →
2 measured ACB analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Aurora Maintains Shareholder Recommendation to Take No Action at this Time as Curaleaf Has Yet to File Their Revised Hostile Bid | Press release | -1.10% | +0.88% | |
| Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB | Press release | +1.26% | +1.68% |
Keep exploring
More ACB: earnings → · SEC filings → · ACB overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| McKesson Corporation (MCK) | 355 | +0.02% | 53% |
| Owens & Minor, Inc. (OMI) | 355 | -0.48% | 34% |
| Avid Bioservices, Inc. (CDMO) | 354 | 0.00% | 49% |
| Celcuity Inc. (CELC) | 354 | +0.13% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.